title: Residual crystals of triamcinolone acetonide in macular hole may prevent complete closure.
authors.forename: Takashi
authors.initials: T
authors.lastname: Koto
authors.forename: Makoto
authors.initials: M
authors.lastname: Inoue
authors.forename: Kei
authors.initials: K
authors.lastname: Shinoda
authors.forename: Susumu
authors.initials: S
authors.lastname: Ishida
authors.forename: Kazuo
authors.initials: K
authors.lastname: Tsubota
mesh_terms: D002648:Child; D003460:Crystallization; D005938:Glucocorticoids / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D008297:Male; D012167:Retinal Perforations / Q000378:metabolism / Q000503:physiopathology* / Q000601:surgery*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism* / Q000627:therapeutic use; D014821:Vitrectomy; D014822:Vitreous Body; D014945:Wound Healing
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide